312
Participants
Start Date
May 13, 2013
Primary Completion Date
September 30, 2019
Study Completion Date
September 30, 2019
XIENCE PRIME SV Everolimus Eluting Coronary Stent
Patients receiving XIENCE PRIME SV Everolimus Eluting Stent
Kimitsu Chuo Hospital, Chiba
Kokura Memorial Hospital, Fukuoka
Fukuoka Wajiro Hospital, Fukuoka
Hoshi general hospital, Fukushima
Tsuchiya General Hospital, Hiroshima
Hyogo Prefectural Amagasaki Hospital, Hyōgo
Tsukuba Medical Center Hospital, Ibaraki
Ishikawa Prefectual Central Hospital, Ishikawa
Shonan Kamakura General Hospital, Kanagawa
Tokai University Hospital, Kanagawa
Kumamoto Chuo Hospital, Kumamoto
Kyoto University Hospital, Kyoto
Miyazaki City-Gun Ishikai Hospital, Miyazaki
Kansai Rosai Hospital, Nagoya
Nagoya Daini Red Cross Hospital, Nagoya
Heart disease center Sakakibara hospital, Okayama
Kurashiki Central Hospital, Okayama
Sakurabashi Watanabe Hospital, Osaka
Osaka police hospital, Osaka
Osaka University Hospital, Osaka
Tokorozawa Heart Center, Saitama
Tokeidai memorial hospital, Sapporo
JCHO Hokkaido Hospital, Sapporo
Hokkaido Ohno hospital, Sapporo
Sendai Kousei Hospital, Sendai
Okamura memorial hospital, Shizuoka
Tokushima Red Cross Hospital, Tokushima
Mitsui Memorial Hospital, Tokyo
Toranomon hospital, Tokyo
Tokyo Women's Medical University Hospital, Tokyo
Teikyo University Hospoital, Tokyo
Showa University Fujigaoka hospital, Yokohama
Saiseikai Yokohama City Tobu Hospital, Yokohama
Lead Sponsor
Abbott Medical Devices
INDUSTRY